NCT00756444
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +9 more
- Locations
-
Not specified
Clinical trial condition
Recurrence
Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.
2,312 public trials
521 recruiting studies
Recurrence trial results
Completed
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies
NCT01499147
- Conditions
- Acute Leukemia, Acute Myeloid Leukemia, Anemia, +51 more
- Locations
-
- University of Illinois at Chicago Medical Center Chicago, Illinois, United States
NCT03732313
- Conditions
- Disease Attributes, Ingrown Toenail, Nail Diseases, +6 more
- Locations
-
Not specified
NCT01965119
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +12 more
- Locations
-
- Busan University Hospital Busan, South Korea
- Dong-A University Busan, South Korea
- Kosin University Gospel Hospital Busan, South Korea
- Asan Medical Center Seoul, South Korea
NCT00038571
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT00963105
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
- Locations
-
- UCSD Moores Cancer Center La Jolla, California, United States
- Desert Hematology Oncology Medical Group, Inc. Rancho Mirage, California, United States
- Stanford University School of Medicine Stanford, California, United States
- Cancer Center of Central Connecticut Southington, Connecticut, United States
NCT03595345
- Conditions
- Behavior, Digestive System Diseases, Digestive System Neoplasms, +14 more
- Locations
-
- UCL Brussels, Belgium
NCT03723499
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoma, +11 more
- Locations
-
- CHU de Saint-Etienne Saint-Etienne, France
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
- Royal Adelaide Hospital Adelaide, South Australia, Australia
- Peter MacCallum Cancer Institute East Melbourne, Victoria, Australia
- Frankston Hospital Frankston, Victoria, Australia
Completed
PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response
NCT00454779
- Conditions
- Disease Attributes, Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, +5 more
- Locations
-
- Research Site Tucson, Arizona, United States
- Research Site Jonesboro, Arkansas, United States
- Research Site Duarte, California, United States
- Research Site La Jolla, California, United States